Morbid obesity in liver transplant recipients adversely affects longterm graft and patient survival in a single-institution analysis

HPB

Volumn 17, Issue 3, 2015, Pages 251-257

  Conzen, Kendra D ^a   Vachharajani, Neeta ^a   Collins, Kelly M ^a   Anderson, Christopher D ^b   Lin, Yiing ^a   Wellen, Jason R ^a   Shenoy, Surendra ^a   Lowell, Jeffrey A ^a   Doyle, M B Majella ^a   Chapman, William C ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; OPERATION DURATION; OVERALL SURVIVAL; PEROPERATIVE COMPLICATION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; ADVERSE EFFECTS; COHORT ANALYSIS; COMPLICATION; END STAGE LIVER DISEASE; FOLLOW UP; GRAFT RECIPIENT; GRAFT REJECTION; MIDDLE AGED; MORTALITY; OBESITY, MORBID; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PROCEDURES; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; SURVIVAL; TIME; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADULT; BODY MASS INDEX; COHORT STUDIES; END STAGE LIVER DISEASE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HOSPITALS, UNIVERSITY; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OBESITY, MORBID; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANT RECIPIENTS; TREATMENT OUTCOME;

EID: 84922614524     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12340     Document Type: Article

References (23)

1. Nair S, Verma S, Thuluvath PJ,. (2002) Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology 35: 105-109.
2. Afzali A, Berry K, Ioannou GN,. (2012) Excellent post-transplant survival for patients with non-alcoholic steatohepatitis in the United States. Liver Transpl 18: 29-37.
3. Agopian VG, Kaldas FM, Hong JC, Whittaker M, Holt C, Rana A, et al. (2012) Liver transplantation for non-alcoholic steatohepatitis: the new epidemic. Ann Surg 256: 624-633.
4. Koehler E, Watt K, Charlton M,. (2009) Fatty liver and liver transplantation. Clin Liver Dis 13: 621-630.
5. Burke A, Lucey MR,. (2004) Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant 4: 686-693.
6. Orci LA, Majno PE, Berney T, Morel P, Mentha G, Toso C,. (2013) The impact of wait list body mass index changes on the outcome after liver transplantation. Transpl Int 26: 170-176.
7. Barritt AS 4th, Dellon ES, Kozlowski T, Gerber DA, Hayashi PH,. (2011) The influence of non-alcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes. J Clin Gastroenterol 45: 372-378.
8. Vanwagner LB, Bhave M, Te HS, Feinglass J, Alvarez L, Rinella ME,. (2012) Patients transplanted for non-alcoholic steatohepatitis are at increased risk for postoperative cardiovascular events. Hepatology 56: 1741-1750.
9. Yalamanchili K, Saadeh S, Klintmalm GB, Jennings LW, Davis GL,. (2010) Non-alcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or non-alcoholic fatty liver disease. Liver Transpl 16: 431-439.
10. LaMattina JC, Foley DP, Fernandez LA, Pirsch JD, Musat AI, D'Alessandro AM, et al. (2012) Complications associated with liver transplantation in the obese recipient. Clin Transplant 26: 910-918.
11. Hawn MT, Bian J, Leeth RR, Ritchie G, Allen N, Bland KI, et al. (2005) Impact of obesity on resource utilization for general surgical procedures. Ann Surg 241: 821-826; discussion 826-828.
12. Williams TK, Rosato EL, Kennedy EP, Chojnacki KA, Andrel J, Hyslop T, et al. (2009) Impact of obesity on perioperative morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg 208: 210-217.
13. Dick AA, Perkins JD, Spitzer AL, Lao OB, Healey PJ, Reyes JD,. (2010) Impact of obesity on children undergoing liver transplantation. Liver Transpl 16: 1296-1302.
14. Ayala R, Grande S, Bustelos R, Ribera C, Garcia-Sesma A, Jimenez C, et al. (2012) Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients. BMC Gastroenterol 12: 114.
15. Nair S, Mason A, Eason J, Loss G, Perrillo RP,. (2002) Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 36: 150-155.
16. Dumortier J, Giostra E, Belbouab S, Morard I, Guillaud O, Spahr L, et al. (2010) Non-alcoholic fatty liver disease in liver transplant recipients: another story of 'seed and soil'. Am J Gastroenterol 105: 613-620.
17. Siegel AB, Lim EA, Wang S, Brubaker W, Rodriguez RD, Goyal A, et al. (2012) Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation. Transplantation 94: 539-543.
18. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. (2009) Body mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373: 1083-1096.
19. Lin MY, Tavakol MM, Sarin A, Amirkiai SM, Rogers SJ, Carter JT, et al. (2013) Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates. Surg Obes Relat Dis 9: 653-658.
20. Heimbach JK, Watt KD, Poterucha JJ, Ziller NF, Cecco SD, Charlton MR, et al. (2013) Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. Am J Transplant 13: 363-368.
21. Guckelberger O,. (2009) Longterm medical comorbidities and their management: hypertension/cardiovascular disease. Liver Transpl 15 (Suppl. 2): 75-78.
22. Desai S, Hong JC, Saab S,. (2010) Cardiovascular risk factors following orthotopic liver transplantation: predisposing factors, incidence and management. Liver Int 30: 948-957.
23. Segev DL, Sozio SM, Shin EJ, Nazarian SM, Nathan H, Thuluvath PJ, et al. (2008) Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials. Liver Transpl 14: 512-525.